Lindbrook Capital’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Other funds holding USNA
Lindbrook Capital's USNA Position: Q1 2025 in Review
Lindbrook Capital reduced its Usana Health Sciences (USNA) stake by 82% in Q1 2025, selling an estimated $4.84K and leaving 34 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #2487.
Lindbrook Capital first reported a position in USNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $17.3K in Q4 2023. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.
- Lindbrook Capital held 34 shares of Usana Health Sciences worth $917 as of Q1 2025.
- Lindbrook Capital sold 153 Usana Health Sciences shares in Q1 2025, an estimated $4.84K.
- Usana Health Sciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2487 holding.
- Lindbrook Capital first reported a position in Usana Health Sciences in Q1 2020 and has held it in 21 quarters since.
- Lindbrook Capital's Usana Health Sciences position peaked at $17.3K in Q4 2023.
- 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.